(19)
(11) EP 2 295 053 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.03.2018 Bulletin 2018/13

(45) Mention of the grant of the patent:
19.10.2016 Bulletin 2016/42

(21) Application number: 10190730.1

(22) Date of filing: 05.12.2003
(51) International Patent Classification (IPC): 
C07D 413/14(2006.01)
C07D 405/12(2006.01)
C07D 417/12(2006.01)
 C07D 311/16(2006.01)
C07D 413/04(2006.01)

(54)

Novel 2H-chromen-2-one-3-carboxamides for medical uses

Neue 2H-Chromen-2-one-3-carboxamide für medizinische Verwendungen

Nouveaux 2H-Chromen-2-one-3-carboxamides pour applications médicales

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 05.12.2002 CN 02155525

(43) Date of publication of application:
16.03.2011 Bulletin 2011/11

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03776786.0 / 1570846

(73) Proprietor: Institute of Materia Medica, Chinese Academy of Medical Sciences
Beijing 100050 (CN)

(72) Inventors:
  • Xu, Shiping
    100050, Xuan Wu District (CN)
  • Chen, Xiaoguang
    100050, Xuan Wu District (CN)
  • Xu, Song
    100050, Xuan Wu District (CN)
  • Li, Lanmin
    100050, Xuan Wu District (CN)
  • Xie, Longfei
    100050, Xuan Wu District (CN)
  • Li, Hongyan
    100050, Xuan Wu District (CN)
  • Li, Yan
    100050, Xuan Wu District (CN)
  • Cheng, Guifang
    100050, Xuan Wu District (CN)

(74) Representative: Daniels, Jeffrey Nicholas 
Page White & Farrer Bedford House John Street
London WC1N 2BF
London WC1N 2BF (GB)


(56) References cited: : 
WO-A1-01/53274
WO-A1-98/34632
FR-A1- 2 763 944
US-A- 2 683 720
 WO-A1-96/40669
CA-A1- 2 445 515
JP-A- 6 145 164
US-A- 5 723 476
   
  • BONSIGNORE L ET AL: "SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 2-OXO-(2H) 1-BENZOPYRAN- 3-CARBOXAMIDE DERIVATIVES", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 28, 1 January 1993 (1993-01-01), pages 517-520, XP002053887, ISSN: 0022-152X
  • CHIMENTI F ET AL: "Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carb oxamides", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 20, no. 16, 15 August 2010 (2010-08-15), pages 4922-4926, XP027172651, ISSN: 0960-894X [retrieved on 2010-06-19]
  • DATABASE Chemical Abstracts, Chemi [Online] 1 January 1980 (1980-01-01), BUX ET AL: "COUMARINS", XP002053894, retrieved from CHEMICAL PAN - 20623d
  • DATABASE Chemical Abstracts, Chemi [Online] 1 January 1981 (1981-01-01), AGRAWAL ET AL: "SOME NEW COUMARINS", XP002053893, retrieved from CHEMICAL PAN - 24726d
  • DATABASE Chemical Abstracts, Chemi [Online] 1 January 1989 (1989-01-01), SHAH ET AL: "SYNTH. OF CARBOXANILIDES A. AMIDES OF 8-METHOYCOUMARIN-3-CARBOXILIC ACID", XP002053891, retrieved from CHEMICAL PAN - 154097p
  • DATABASE Chemical Abstracts, Chemi [Online] 1 January 1992 (1992-01-01), MOUSTAFA ET AL: "SYNTH. OF SOME COUMARIN-3-(4-AMINOSULFONYL)CARBANILIDE DERIV", XP002053890, retrieved from CHEMICAL PAN - 255441a
  • DATABASE Chemical Abstracts, Chemi [Online] 1 January 1992 (1992-01-01), SELIM ET AL: "REACTIONS OF 3-CARBOETHOXY-6-BROMO COUMARINS", XP002053889, retrieved from CHEMICAL PAN - 150840x
  • DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SIMONYAN, A. V. ET AL: "Electron topological study of the structure-antiallergic activity relationship in derivatives of chalcone, coumarin, and cinnamic acid", XP007916598, retrieved from STN Database accession no. 1994:124164
  • DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; EL-KERDAWY, M. M. ET AL: "Application of the Knoevenagel condensation to 4-acetamidophenazone derivatives", XP007916599, retrieved from STN Database accession no. 1988:630878
  • DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SARAF, A. S. ET AL: "Synthesis and antiallergic activity in the series of cinnamic acid derivatives", XP007916600, retrieved from STN Database accession no. 1993:559802
  • DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ZHANG, YUANLANG ET AL: "Chemotherapeutic studies on schistosomiasis. XXV. Derivatives of substituted coumarin-3-carboxylic esters and amides", XP007916601, retrieved from STN Database accession no. 1982:135383
  • DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SELLERI, R. ET AL: "Coumarin derivatives of pharmaceutical interest", XP007916602, retrieved from STN Database accession no. 1968:402804 & SELLERI, R. ET AL: "Coumarin derivatives of pharmaceutical interest", BOLLETTINO CHIMICO FARMACEUTICO , 106(10), 680-7 CODEN: BCFAAI; ISSN: 0006-6648, 1967, XP008130983,
  • G. PARKER, A. ROBERTSON: "Experiments on the Synthesis of rotenone and its derivatives. XVII. The Rotenonone Nucleus", JOURNAL OF THE CHEMICAL SOCIETY, 1950, pages 1121-1124, XP002635867, ISSN: 0368-1769
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).